Article
A cross-sectional study examining the expression of splice variants K-RAS4A and K-RAS4B in advanced non-small-cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) - 1 Feb 2018
Aran Veronica, Masson Domingues Pedro, Carvalho de Macedo Fabiane, Moreira de Sousa Carlos Augusto, Caldas Montella Tatiane, de Souza Accioly Maria Theresa, Ferreira Carlos Gil
Abstract excerpt
OBJECTIVES: Mammalian cells differently express 4 RAS isoforms: H-RAS, N-RAS, K-RAS4A and K-RAS4B, which are important in promoting oncogenic processes when mutated. In lung cancer, the K-RAS isoform is the most frequently altered RAS protein, being also a difficult therapeutic target. Interestingly, there are two K-RAS splice variants (K-RAS4A and K-RAS4B) and little is known about the role of K-RAS4A. Most...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
